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Abstract
Background: Sedation prior to performance of diagnostic esophagogastroduodenoscopy (EGDE) is widespread
and increases patient comfort. But 98% of all serious adverse events during EGDEs are ascribed to sedation. The S3
guideline for sedation procedures in gastrointestinal endoscopy published in 2008 in Germany increases patient
safety by standardization. These new regulations increase costs because of the need for more personnel and a
prolonged discharge procedure after examinations with sedation. Many patients have difficulties to meet the
discharge criteria regulated by the S3 guideline, e.g. the call for a second person to escort them home, to resign
from driving and working for the rest of the day, resulting in a refusal of sedation. Therefore, we would like to
examine if an acupuncture during elective, diagnostic EGDEs could increase the comfort of patients refusing
systemic sedation.
Methods/Design: A single-center, double blinded, placebo controlled superiority trial to compare the success rates
of elective, diagnostic EGDEs with real and placebo acupuncture. All patients aged 18 years or older scheduled for
elective, diagnostic EGDE who refuse a systemic sedation are eligible. 354 patients will be randomized. The primary
endpoint is the rate of successful EGDEs with the randomized technique. Intervention: Real or placebo acupuncture
before and during EGDE. Duration of study: Approximately 24 months.
Discussion: Organisation/Responsibility The ACUPEND - Trial will be conducted in accordance with the protocol
and in compliance with the moral, ethical, and scientific principles governing clinical research as set out in the
Declaration of Helsinki (1989) and Good Clinical Practice (GCP). The Interdisciplinary Endoscopy Center (IEZ) of the
University Hospital Heidelberg is responsible for design and conduct of the trial, including randomization and
documentation of patients’ data. Data management and statistical analysis will be performed by the independent
Institute for Medical Biometry and Informatics (IMBI) and the Center of Clinical Trials (KSC) at the Department of
General, Visceral and Transplantation Surgery, University of Heidelberg.
Trial registration: The trial is registered at Germanctr.de (DRKS00000164) on December 10th 2009. The first patient
was randomized on February 2nd 2010.
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Background
More than 10 million gastrointestinal (GI) endoscopic
procedures are performed every year in the United States
only [1,2]. The standard use of systemic sedation to facili-
tate the performance of esophagogastroduodenoscopy
(EGDE) and to increase patient comfort has contributed
to the widespread use and acceptance of this procedure.
But the perceived benefits of improved patient comfort
and satisfaction afforded by parenteral sedation must be
measured against the increased risk of adverse cardiopul-
monary events and higher attendant costs [3]. Complica-
tions that arise from EGDE are usually associated with
the use of systemic sedation and the dose given. More
than 98% of serious adverse events in upper GI endo-
scopy like hypotension, aspiration and respiratory depres-
sion are ascribed to systemic sedation [4].
Recently, the first S3-guideline for sedation in GI
endoscopy in Germany was published to improve
patient safety, which demands additional trained person-
nel and endoscopy equipment [5]. Therefore, it is esti-
mated that sedation and related issues account for up to
40% of total endoscopy costs including overhead and
indirect costs [6]. In detail, an additional specialized
nurse or physician is required to perform and monitor
systemic sedation. Furthermore, systemic sedation
impedes the rapid discharge from the hospital, resulting
in absence of work of patients concerned.
Acupuncture has been used as a part of Traditional
Chinese Medicine (TMC) for more than 2000 years [7].
Many studies have investigated the benefits and success
of acupuncture in reducing pain for various acute and
chronic diseases. However, most of them had methodo-
logical difficulties, e.g. the inclusion of an adequate con-
trol group [8]. A Cochrane review from 2009 on
acupuncture for migraine prophylaxis reports that even
acupuncture at the “wrong” place (sham-acupuncture)
could have a significant effect on the primary endpoint
[9]. Therefore, the use of a real placebo needle is neces-
sary. With the introduction of a placebo acupuncture
needle system some years ago a new and valid instru-
ment to measure placebo effects became available
(Figure 1) [10].
If the use of acupuncture could improve tolerance and
examination quality of diagnostic EGDE without seda-
tion it should be possible to increase the willingness of
patients to undergo this examination without systemic
sedation. Consequently, it would be possible to reduce
the rate of serious adverse events due to systemic seda-
tion and to lower the costs for personnel and material.
Up to now, only one double-blind, controlled trial with
90 patients undergoing EGDE was performed in 1978,
using real versus sham-acupuncture (1 cm away from the
acupuncture point) with 10 needles and electrical stimu-
lation and showing that upper endoscopy was much
easier and better tolerated after real acupuncture [11].
But this study misses a clearly defined primary endpoint
and a detailed sample size calculation and has the disad-
vantage of using sham-acupuncture instead of a real pla-
cebo acupuncture technique in the control group. An
adequately designed randomized double-blinded placebo
controlled clinical trial with a well-defined primary end-
point and detailed sample size calculation comparing pla-
cebo acupuncture versus real acupuncture to improve
success rates in EGDE has not yet been conducted.
Methods/Design
Aim of study
The objective of this trial is to compare the rate of suc-
cessful EGDE (combination of patients’ satisfaction and
examination quality) in patients receiving pharyngeal
anaethesia as well as either real or placebo acupuncture.
Number of patients needed
The sample size calculation is based on the two-sided
chi-square test for difference with respect to the primary
endpoint.
A review of the previous literature identified a rando-
mized controlled trial from Abraham et al. with a group
of 419 patients comparing the rate of successful EDGE
with and without sedation [12]. In both groups a phar-
yngeal anaesthesia was performed. This trial showed a
Figure 1 Image of real and placebo acupuncture needle
system.
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successful examination rate of 46% in the group without
sedation. A successful examination was defined as a
composite score of patient satisfaction with the proce-
dure as well as quality of the examination (technical
adequacy) as assessed by the endoscopist. These were
determined by the administration of standardized Likert
scales (patient satisfaction on a scale of 1-5, quality of
examination on a scale of 1-4). An EDGE examination
was only counted as successful if the patient rated 1 or
2 on the satisfaction scale and the endoscopist rated 4
on the quality of examination scale. Based on the results
from this large trial we decided to adapt the definition of
successful EDGE for our trial and use the 46% success
rate of the non sedated group as baseline for the sample
size calculation. We believe that an increase of the suc-
cess rate by 15% or more to > = 61% in the acupuncture
group would be clinically relevant and therefore could
impact clinical practice. To detect this difference at a
type I error rate of a = 0.05 (two-sided) with power 1-b
= 80%, a sample size of n = 173 evaluable patients per
group is necessary (SAS 9.1 proc power). The drop out
rate within the intervention is expected to be about 2%
overall. Therefore, another 8 patients in total have to be
randomized to obtain the required number of evaluable
patients. The total number of patients needed to be ran-
domized is therefore 354 (Figure 2).
Eligibility
Inclusion criteria
• Age equal or greater than 18 years
• Patients scheduled for elective diagnostic EGDE
without systemic sedation
Exclusion criteria
• Patients classified ASA V
• Participation in another clinical trial which could
interfere with the primary endpoint of this study
• Expected lack of compliance
• Impaired mental state or language problems
• Patients with known allergy to lidocaine anaes-
thetic spray or acupuncture needle material
• Necessity of systemic sedation
• Emergency procedures
• Pregnancy
Subject withdrawal criteria
• At their own request or at request of the legal
representative
• If, in the investigator’s opinion (physician perform-
ing the acupuncture or physician performing the
examination), continuation of the trial would be
detrimental to the subject’s well-being (e.g. strong
pain at the insertion points, allergical reactions,
other independent acute health problems).
All withdrawn patients will be reported in the final
results to guarantee maximum transparency.
Consent
The ACUPEND- Trial will be conducted in accordance
with the protocol and in compliance with the moral,
ethical, and scientific principles governing clinical
research as set out in the Declaration of Helsinki 1989
[13] and Good Clinical Practice http://www.ema.europa.
eu/docs/en_GB/document_library/Scientific_guideline/
2009/09/WC500002874.pdf. The protocol was approved
by the Ethics Committee of the University of Heidelberg
(S-273/2009). All patients scheduled for an elective diag-
nostic EGDE in the Interdisciplinary Center of Endo-
scopy (IEZ) of the Department of General, Visceral and
Transplantation Surgery and the Department of Internal
Medicine of the Universitiy of Heidelberg will be
screened, informed about the ACUPEND trial and
included by physicians of the IEZ supervising in this
trial. The study procedure, risks, benefits and data man-
agement will be clarified in detail before the patients are
asked to give their informed consent.
Randomization and procedures for minimizing bias
The study protocol was designed according to the Stan-
dards for reporting Interventions in Clinical Trials
Acupuncture (STRICTA) [14].
Minimizing bias To achieve comparable groups for
known and unknown risk factors, randomization will be
performed as a block randomization with alternating
block size. Allocation to treatment group will be per-
formed by sealed consecutively numbered envelopes
prepared by the Institute of Medical Biometry and Infor-
matics of the University of Heidelberg (IMBI). Randomi-
zation will be carried out after the patient has signed
the informed consent form and will be documented in
the case report file of every patient. The allocation will
be controlled by a monitor.
Minimizing treatment bias All physicians who partici-
pate in this trial will be trained and updated every
3 month to improve comparable treatment of patients.
Special manuals will be used in the Interdisciplinary
Center for Endoscopy (IEZ) to reduce errors. Acupunc-
ture will be performed by physicians of the department
of the Interdisciplinary endoscopy center (IEZ) who
were trained by experienced acupuncturists with level B
diploma and who performed at least 20 acupuncture
procedures explained in the intervention chapter under
supervision. Furthermore the PS3 device will be used to
support the localisation of the correct acupuncture
points by measuring loss of skin resistance.
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Minimizing measurement bias A study nurse or physi-
cian will document and monitor the procedure in the
endoscopy and recovery room. Before the endoscopic
procedure is performed the acupuncturist will open the
allocation envelope. The physician performing the
EGDE and the assistant nurse will not be informed
about the allocation. Once patients are randomized they
will be included into the analysis according to the prin-
ciple of intention to treat.
Study treatment
Patients who are scheduled for EGDE will be screened and
informed by a member of the IEZ about the trial before
their EGDE procedure. After signing the informed consent
form the patients will be prepared by staff nurses for the
procedure as usual. A study nurse or physician will be pre-
sent to monitor and document the procedures (Table 1).
All patients will be positioned on a stretcher lying on
their backs with 30 degrees reverse Trendelenburg’s
To be assessed  
for eligibility 
To be randomised 
Received allocated 
intervention
Did not receive 
allocated intervention  
Total to be excluded: 
Not meeting inclusion 
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Intervention Group B 
Real Acupuncture 
ITT Analysis 
PP Analysis 
Intervention Group A 
Placebo Acupuncture
Received allocated 
intervention
Did not receive 
allocated intervention  
ITT Analysis  
PP Analysis 
Figure 2 Flowchart according to CONSORT.
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position. Standard monitoring with SaO2 and non-
invasive blood pressure will be established. Pharyngeal
anaesthesia will be performed with a topical xylocaine
spray (AstraZeneca, Germany) in all patients by a
nurse or physician.
According to the allocation the procedure will be con-
tinued We based the acupuncture point selections on
Traditional Chinese Medicine meridian theory to
improve tolerance and examination quality of diagnostic
EGDE [15].
Intervention-group A (placebo acupuncture) All
patients will receive placebo acupuncture at the following
points according to the procedure of the Streitberger pla-
cebo acupuncture needle system (Figures 1 and 3) [10]:
KG 24 Chengjiang middle line (to reduce choking)
[15]
Pericard 6 Neiguan bilateral (to reduce gastroent-
eral motility) [16]
Di 4 Yangxci bilateral (to reduce nausea and
vomiting) [17]
Half to one inch 32G needles (0.32 × 30 mm stainless
steel needle from asia med company, Munich, Germany)
will be placed and left in their position for five minutes
prior and throughout the endoscopic procedure.
Intervention-group B (real acupuncture) After the
described preparation patients will receive a real acu-
puncture at the following acupuncture points:
KG 24 Chengjiang middle line (to reduce choking)
[15]
Pericard 6 Neiguan bilateral (to reduce gastro-
enteral motility) [16]
Di 4 Yangxci bilateral (to reduce nausea and
vomiting) [17]
Half to one inch 32G needles (0.32 × 30 mm stainless
steel needle from asia med company, Munich, Germany)
will be placed into these points, stimulated for 1-2 sec-
onds to induce de qi sensation and left in this position
for five minutes prior and throughout the endoscopic
procedure.
To perform EGDE all patients in both groups will be
turned on their left side still with a 30 degree reverse
Trendelenburg’s position.
Primary and secondary endpoints
Primary endpoint The primary endpoint will be the
rate of successful diagnostic EGDE.
Definition of the primary endpoint Rate of successful
elective diagnostic EGDE is defined as a composite
score of patient satisfaction with the procedure as well
as quality of the examination (technical adequacy) as
assessed by the examiner. These were determined by the
administration of standardized Likert scales.
Assessment of the primary endpoint Immediately after
the elective diagnostic EGDE, the examiner scores the
technical adequacy of the examination. Each anatomic
area (esophagus, stomach, duodenum up to the second
stage, and proximal stomach viewed in retroflexion) that
was adequately viewed receives a score of 1 versus 0 if
inadequately viewed, for a maximum score (4/4) if all
four main anatomic areas of the examination were well
visualized. The result will be documented in the CRF
with tick boxes by the physician who performed the
examination.
The patients are asked to rate their satisfaction with
the examination after the completion of EGDE, prior to
being told the results of their procedure and prior to
discharge from the recovery room, on a Likert scale
from 1 = acceptable to 5 = unacceptable. The results
Table 1 Study Visit Schedule
Day of screening and
intervention
Past medical history* X
Informed consent X
Personal data** X
Examination of primary endpoints: X
• Success of EGDE
Examination of secondary endpoints:
• Heart rate X
• Blood pressure X
• Oxygen saturation X
• Duration of examination X
• Willingness to repeat examination under
same conditions
X
• Periinterventional complications X
Safety criteria AE, SAE (2.6) X
*study-relevant past medical history, past surgical history.
** height (cm), weight (kg), gender, smoking customs, chemotherapy,
existence of false teeth.
Figure 3 Inserted acupuncture needle.
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will be documented in the CRF with tick boxes by a
nurse or physician. An EGDE will be counted as success
if patients’ satisfaction is 1 or 2 on the Likert scale and
the examination quality score is 4/4 [12,18-20].
Secondary endpoints The willingness to repeat the
procedure is defined as readiness of the patient to
repeat the examination under the same conditions and
will be recorded in the CRF with tick boxes (yes/no)
by a nurse or physician. Heart rate (beats per minute),
blood pressure (mmHg) and oxygen saturation (per
cent) will be assessed before EGDE, after passage of
the larynx and after removal of the endoscope. The
results will be documented in the CRF by a nurse or
physician. The duration of the examination in minutes
from insertion to removal of the endoscope will be
documented in the CRF. Furtheremore periinterven-
tional complications as described and defined in Table
2 will be documented.
Safety aspects
Specification of safety variables The correct placement
of the needles will be checked and if necessary replaced
by the physician who performed the acupuncture right
before the examination. After endoscopic examination
the needles will be checked again. If some of the needles
are not in place after examination it will be documented
in the CRF.
Concomitant medication Every patient can be switched
to systemic sedation at anytime to successfully complete
the EGDE if necessary or at the patient’s wish. The con-
version will be documented in the CRF and the patient’s
satisfaction will be counted as 5/5 (unacceptable) on the
Likert scale. Therefore, the need for systemic sedation is
defined as unsuccessful EGDE for both intervention
groups.
Past medical history Prior and concomitant illness of
the patients will be documented in the CRF.
Adverse events and serious adverse events AEs will be
reported to the principal investigator in regular intervals
during the course of the study. SAEs will be documen-
ted on a special SAE form in the CRF and will be
reported to the principal investigator within 24h.
Analysis
Analysis sets Each patient’s allocation to the different
analysis populations (full analysis set (FAS) according to
the intention-to-treat (ITT) principle, per protocol (PP)
analysis set, safety analysis set) will be defined prior to
the analysis. The allocation will be documented in the
statistical analysis plan. During the data review, devia-
tions from the protocol will be assessed as “minor” or
“major”. Major deviations from the protocol will lead to
the exclusion of a patient from the PP analysis set.
Confirmatory analysis The null hypothesis H is
assessed by testing the intervention effect in a primary
analysis using a two-sided chi-square test. In a second-
ary analysis a binary logistic regression model that takes
into account the covariates “intervention” (placebo/acu-
puncture), age (< 65,≥ 65) and gender will be used.
A two-sided type I error rate of a = 0.05 will be applied
to the primary and secondary analysis.
Confirmatory analysis will be primarily based on the
FAS which is consistent with the intention-to-treat
(ITT) principle, by including all patients who were ran-
domized into the two groups. This approach reflects the
idea that the study should correspond to the conditions
in clinical practice as closely as possible.
Further analysis In addition to the evaluation of the
FAS, a PP analysis will be performed including all ran-
domized patients without major protocol violations.
The secondary variables will be analyzed in a descrip-
tive manner by tabulation of the measures of the
empirical distributions. According to the scale level of
the variables, means, standard deviations, medians, 1st
and 3rd quartiles as well as minimum and maximum or
absolute and relative frequencies, respectively, will be
reported. Descriptive p-values of the corresponding sta-
tistical tests comparing the treatment groups and asso-
ciated 95% confidence intervals will be given.
Homogeneity of the treatment groups The homogene-
ity of the treatment groups will be demonstrated
descriptively using the demographic data and the base-
line values. All statistical analyses will be performed
using SAS® software, Version 9.1 (or higher) of the SAS
System for Unix (SAS Institute Inc., Cary, NC, USA).
Study organization
After approval of the protocol by the local ethics com-
mittee of the University of Heidelberg, the trial was inter-
nationally registered at Germanctr.de (DRKS00000164).
All patients scheduled for elective, diagnostic EGDE in
the Interdisciplinary Endoscopy Center (IEZ) who refuse
sedation will be referred to and screened by members
of IEZ or the Clinical Study Center Surgery (KSC).
The result of the screening will be recorded in the
screening-log.
Approximately 4300 patients per year undergo an
EGDE including about 900 patients without systemic
Table 2 Definitions of periinterventional complications
Complication Definition
Haematoma Clinical diagnosis
Bleeding Clinical diagnosis
Nerve irritation Clinical diagnosis
Bradycardy Heart rate < 60 beats per minute
Hypotension Blood pressure < 90 mmHg systolic
Low oxygen saturation Oxygen saturation < 92%
Aspiration Clinical diagnosis and radiological findings
Wound infection Clinical diagnosis
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sedation in the Interdisciplinary Center for Endoscopy
(IEZ) of the Universitiy of Heidelberg. The estimated
time frame to randomize 354 patients is 20 months.
Sponsor of the ACUPEND trial is the University Hos-
pital of Heidelberg.
The independent data management and statistical analy-
sis will be carried out by the Institute of Medical Biometry
and Informatics (IMBI) of the University of Heidelberg
according to a prespecified Statistical Analysis Plan.
The principal investigator has the right to terminate
the trial and to remove all trial material from the trial
centre at any time in consultation with the Clinical
Study Team Leader and the Biostatistician. Reasons that
may require a termination of the trial include the
following:
• The incidence or severity of adverse events in this
trial indicates a potential health hazard caused by
the study treatment
• It appears that patient’s enrolment is unsatisfactory
with respect to quality or quantity or data recording
is severely inaccurate or incomplete
• External evidence that renders the necessity to ter-
minate the trial
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